CCR5 and HIV-1 infection: Further, the n-butanol fraction exhibited a marked decrease in HIV-1 infection by HIV-1BaL (R-5 tropic) as well as displayed a potent inhibition of infection of primary isolates of CCR5-tropic HIV-1 at non-cytotoxic concentrations.